Thiothixene
Back to searchMolecule Structure
Scientific Name
Thiothixene
Description of the Drug
Thiothixene is an antipsychotic indicated for the management of schizophrenia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01623
http://www.drugbank.ca/drugs/DB01623
Brand Name(s)
Navane, Orbinamon, Thiothixene
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Paco Research Corp, Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc, Sandoz Inc, American Therapeutics Inc, Watson Laboratories Inc, Alpharma Us Pharmaceuticals Division, Epic Pharma Inc, Mylan Pharmaceuticals Inc, Amneal Eu Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34305 | |
PharmGKB | PA451669 | |
Human Metabolome Database | HMDB0015560 | |
DrugBank | DB01623 | |
PubChem: Thomson Pharma | 14759539 | |
PubChem | 941651 | |
Nikkaji | J902D | |
BindingDB | 78576 | |
EPA CompTox Dashboard | DTXSID2091542 | |
DrugCentral | 2639 | |
ChemicalBook | CB2102597 | |
Guide to Pharmacology | 212 | |
rxnorm | THIOTHIXENE | THIOTHIXENE HYDROCHLORIDE |
PubChem: Drugs of the Future | 12013417 | |
ChEBI | 9571 | |
ZINC | ZINC000030690433 |